Ipatasertib
Product Specifications
CAS Number
1001264-89-6
Target
Apoptosis|||Akt
Related Pathways
PI3K/Akt/mTOR signaling|||Cytoskeletal Signaling|||Apoptosis
Purity
0.9979
Bioactivity
Ipatasertib (GDC-0068) is a selective, ATP-competitive pan-Akt inhibitor that inhibits Akt1 (IC50:5 nM), Akt2 (IC50:18 nM), and Akt3 (IC50:8 nM) . Ipatasertib (GDC-0068) can lead to p53-independent PUMA activation by inhibiting Akt, thereby activating FoxO3a and NF-?B simultaneously, directly binding to the PUMA promoter, upregulating PUMA transcription and Bax-mediated intrinsic mitochondrial apoptosis.
Smiles
C[C@H]1C2=C(N=CN=C2[C@H](O)C1)N3CCN(C([C@H](CNC(C)C)C4=CC=C(Cl)C=C4)=O)CC3
Molecular Formula
C24H32ClN5O2
Molecular Weight
458
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/F27CB79B-821A-450D-8601-456AD3BAF52E/T6252
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human Monoclonal ICOS Antibody (feladilimab) [Janelia Fluor 585]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP3-28241JF585 0.1 mL
Human Monoclonal ICOS Antibody (feladilimab) [Janelia Fluor 585]
Ask
View Details 
